Transplacental Distribution of Lidocaine and Its Metabolite in Peridural Anesthesia Administered to Patients With Gestational Diabetes Mellitus
- PMID: 25563756
- PMCID: PMC4565472
- DOI: 10.1177/1933719114561560
Transplacental Distribution of Lidocaine and Its Metabolite in Peridural Anesthesia Administered to Patients With Gestational Diabetes Mellitus
Abstract
Background: Neonatal effects of drugs administered to mothers before delivery depend on the quantity that crosses the placental barrier, which is determined by the pharmacokinetics of the drug in the mother, fetus, and placenta. Diabetes mellitus can alter the kinetic disposition and the metabolism of drugs. This study investigated the placental transfer of lidocaine and its metabolite monoethylglycinexylidide (MEGX) in pregnant women with gestational diabetes mellitus (GDM) submitted to peridural anesthesia.
Patients and methods: A total of 10 normal pregnant women (group 1) and 6 pregnant women with GDM (group 2) were studied, all at term. The patients received 200 mg 2% lidocaine hydrochloride by the peridural locoregional route. Maternal blood samples were collected at the time of delivery and, after placental expulsion, blood samples were collected from the intervillous space, umbilical artery, and vein for determination of lidocaine and MEGX concentrations and analysis of the placental transfer of the drug.
Results: The following respective lidocaine ratios between the maternal and the fetal compartments were obtained for groups 1 and 2: umbilical vein/maternal peripheral blood, 0.60 and 0.46; intervillous space/maternal blood, 1.01 and 0.88; umbilical artery/umbilical vein, 0.77 and 0.91; and umbilical vein/intervillous space, 0.53 and 0.51. The following MEGX ratios for groups 1 and 2 were, respectively, fetal/maternal, 0.43 and 0.97; intervillous space/maternal blood, 0.64 and 0.90; umbilical artery/umbilical vein, 1.09 and 0.99; and umbilical vein/intervillous space, 0.55 and 0.78.
Conclusion: Gestational diabetes mellitus did not affect the transplacental transfer of lidocaine but interfered with the transfer of MEGX, acting as a mechanism facilitating the transport of the metabolite.
Keywords: gestational diabetes mellitus; lidocaine; monoethylglycinexylidide; placental transfer; pregnancy.
© The Author(s) 2015.
Conflict of interest statement
Similar articles
-
Distribution of bupivacaine enantiomers and lidocaine and its metabolite in the placental intervillous space and in the different maternal and fetal compartments in term pregnant women.J Clin Pharmacol. 2011 Feb;51(2):212-7. doi: 10.1177/0091270010365551. Epub 2010 Apr 16. J Clin Pharmacol. 2011. PMID: 20400649 Clinical Trial.
-
Pharmacokinetics of lidocaine and its metabolite in peridural anesthesia administered to pregnant women with gestational diabetes mellitus.Eur J Clin Pharmacol. 2008 Dec;64(12):1189-96. doi: 10.1007/s00228-008-0544-0. Epub 2008 Aug 6. Eur J Clin Pharmacol. 2008. PMID: 18679666 Clinical Trial.
-
Pharmacokinetics and transplacental transfer of lidocaine and its metabolite for perineal analgesic assistance to pregnant women.Eur J Clin Pharmacol. 2004 Oct;60(8):569-74. doi: 10.1007/s00228-004-0798-0. Epub 2004 Sep 7. Eur J Clin Pharmacol. 2004. PMID: 15365654 Clinical Trial.
-
[Amniotic fluid insulin levels versus mean maternal blood glucose levels in gestational diabetes mellitus: an analysis of the neonatal outcome].Gynakol Geburtshilfliche Rundsch. 2009;49(4):249-53. doi: 10.1159/000301081. Epub 2010 May 19. Gynakol Geburtshilfliche Rundsch. 2009. PMID: 20530937 Review. German.
-
Oral hypoglycemic therapy: understanding the mechanisms of transplacental transfer.J Matern Fetal Neonatal Med. 2010 Mar;23(3):224-8. doi: 10.3109/14767050903550881. J Matern Fetal Neonatal Med. 2010. PMID: 20064105 Review.
Cited by
-
Physico-chemical properties and gestational diabetes predict transplacental transfer and partitioning of perfluoroalkyl substances.Environ Int. 2019 Sep;130:104874. doi: 10.1016/j.envint.2019.05.068. Epub 2019 Jun 11. Environ Int. 2019. PMID: 31200157 Free PMC article.
-
Effect of type 2 diabetes mellitus on the pharmacokinetics and transplacental transfer of nifedipine in hypertensive pregnant women.Br J Clin Pharmacol. 2017 Jul;83(7):1571-1579. doi: 10.1111/bcp.13226. Epub 2017 Jan 29. Br J Clin Pharmacol. 2017. PMID: 28042936 Free PMC article.
References
-
- Preston RA, Chung M, Gaffney M, Alonso A, Baltodano NM, Epstein M. Comparative pharmacokinetics and pharmacodynamics of amlodipine in hypertensive patients with and without type II diabetes mellitus. J Clin Pharmacol. 2001;41 (11):1215–1224. - PubMed
-
- Preston RA, Epstein M. Effects of diabetes on cardiovascular drug metabolism. Emerging clinical implications. Diabetes Care. 1999;22 (6):982–988. - PubMed
-
- Calderon IMP, Damasceno DC, Amorin RL, Costa RAA, Brasil MAM, Rudge MVC. Morphometric study of placental villi and vessels in women with mild hyperglycemia or gestational or overt diabetes. Diabetes Res Clin Pract. 2007;78 (1):65–71. - PubMed
-
- Pasanen M, Pelkonen O. Human placental xenobiotic and steroid biotransformations catalyzed by cytochrome P450, epoxide hydrolase, and glutathione S-transferase activities and their relationships to maternal cigarette smoking. Drug Metab Rev. 1990;21 (3):427–461. - PubMed
-
- Little BB. Pharmacokinetics during pregnancy: evidence-based maternal dose formulation. Obstet Gynecol. 1999;93 (5 pt 2):858–868. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources